Buscar
Immatics NV
IMTXAñadir a la lista de seguimiento
8.220USD
-0.380-4.42%
Horarios del mercado 09/24, 12:53（ET）
1.12BCap. mercado
PérdidaP/E TTM
Acerca de Immatics NV Compañía
Immatics NV is a clinical-stage biopharmaceutical company that is based in the Netherlands. The Company is focused on the discovery and development of T-Cell eceptors with the goal of enabling a robust and specific T-Cell response against these targets. The Company develops targeted immunotherapies with an emphasis on treating solid tumors through two distinct therapeutic modalities: Adoptive Cell Therapies (ACT) and antibody-like TCR Bispecifics (TCER). Its wholly owned pipeline comprises of eight therapeutic programs, of which four are in clinical trials, including IMA201 (MAGEA4/8), IMA202 (MAGEA1) and ACTolog IMA 101 (Multi-target pilot trial) for solid cancers and IMA203 (PRAME) for hematological and solid cancers, as well as four are in preclinical development, including IMA204 (COL6A3) and IMA401 (Cancer testis antigen) for solid cancers, and ACTallo IMA301 (Cancer testis antigen) and IMA402 (Cancer testis antigen) for hematological and solid cancers.
Perfil de Immatics NV
Símbolo de cotizaciónIMTX
Nombre de la empresaImmatics NV
Fecha de salida a bolsaJul 02, 2020
Director ejecutivoSingh (Harpreet)
Número de empleados297
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 02
DirecciónPaul Ehrlich-Strasse 15
CiudadTUEBINGEN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísGermany
Código postal72076
Teléfono4970715397700
Sitio Webhttps://immatics.com/
Símbolo de cotizaciónIMTX
Fecha de salida a bolsaJul 02, 2020
Director ejecutivoSingh (Harpreet)
Ejecutivos de Immatics NV
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Steffen Walter, Ph.D.
Dr. Steffen Walter, Ph.D.
Chief Operating Officer
Chief Operating Officer
502.83K
+24.29%
Dr. Steffen Walter, Ph.D.
Dr. Steffen Walter, Ph.D.
Chief Operating Officer
Chief Operating Officer
502.83K
+24.29%
Dr. Steffen Walter, Ph.D.
Dr. Steffen Walter, Ph.D.
Chief Operating Officer
Chief Operating Officer
502.83K
+24.29%
Dr. Mathias Hothum, Ph.D.
Dr. Mathias Hothum, Ph.D.
Non-Executive Director
Non-Executive Director
394.52K
+10.14%
Dr. Mathias Hothum, Ph.D.
Dr. Mathias Hothum, Ph.D.
Non-Executive Director
Non-Executive Director
394.52K
+10.14%
Dr. Mathias Hothum, Ph.D.
Dr. Mathias Hothum, Ph.D.
Non-Executive Director
Non-Executive Director
394.52K
+10.14%
Mr. Jordan Silverstein
Mr. Jordan Silverstein
Head of Strategy
Head of Strategy
384.98K
+26.63%
Mr. Jordan Silverstein
Mr. Jordan Silverstein
Head of Strategy
Head of Strategy
384.98K
+26.63%
Mr. Jordan Silverstein
Mr. Jordan Silverstein
Head of Strategy
Head of Strategy
384.98K
+26.63%
Mr. Edward Sturchio, J.D.
Mr. Edward Sturchio, J.D.
General Counsel
General Counsel
300.63K
+33.47%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Steffen Walter, Ph.D.
Dr. Steffen Walter, Ph.D.
Chief Operating Officer
Chief Operating Officer
502.83K
+24.29%
Dr. Steffen Walter, Ph.D.
Dr. Steffen Walter, Ph.D.
Chief Operating Officer
Chief Operating Officer
502.83K
+24.29%
Dr. Steffen Walter, Ph.D.
Dr. Steffen Walter, Ph.D.
Chief Operating Officer
Chief Operating Officer
502.83K
+24.29%
Dr. Mathias Hothum, Ph.D.
Dr. Mathias Hothum, Ph.D.
Non-Executive Director
Non-Executive Director
394.52K
+10.14%
Dr. Mathias Hothum, Ph.D.
Dr. Mathias Hothum, Ph.D.
Non-Executive Director
Non-Executive Director
394.52K
+10.14%
Dr. Mathias Hothum, Ph.D.
Dr. Mathias Hothum, Ph.D.
Non-Executive Director
Non-Executive Director
394.52K
+10.14%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Immatics NV?
Los cinco principales accionistas de Immatics NV son: Dr. Steffen Walter, Ph.D.
¿Cuántas instituciones poseen acciones de Immatics NV (IMTX)?
A fecha de 2026Q1, 191 instituciones poseen acciones de Immatics NV, con un valor de mercado combinado de aproximadamente 101.84M, lo que representa el 75.94% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -17425391.00.